首页 | 本学科首页   官方微博 | 高级检索  
检索        

成人特发性膜性肾病血清抗M型磷脂酶A2受体抗体与病情的相关性研究
引用本文:张丽丽,王祥,范小丽,王晓丽,赵军.成人特发性膜性肾病血清抗M型磷脂酶A2受体抗体与病情的相关性研究[J].中国现代医学杂志,2016,26(9):44-48.
作者姓名:张丽丽  王祥  范小丽  王晓丽  赵军
作者单位:1.潍坊医学院,山东 潍坊 261042;2.山东省潍坊市人民医院,山东 潍坊 261000
摘    要:

目的  通过研究成人特发性膜性肾病(IMN)血清抗M型磷脂酶A2受体(PLA2R)抗体的阳性滴度与其他实验室指标的相关性,进一步探讨抗PLA2R抗体对IMN诊断及病情评估的作用。方法  选取B超引导下肾穿刺活检证实为IMN患者55例,追踪观察6个月,同时选取15例健康体检者为对照组,应用酶联免疫吸附法(ELISA)检测血清抗PLA2R抗体,同时对IMN患者24 h尿蛋白定量、血清总蛋白、血清白蛋白、血清总胆固醇、血清肌酐进行检测。结果  经过3和6个月治疗后,血清抗PLA2R抗体较治疗前降低(P <0.05)。55例IMN患者治疗前血清抗PLA2R抗体阳性患者47例,阳性率为85.45%;治疗3个月后血清抗PLA2R抗体阳性患者36例,阳性率为65.45%,治疗6个月后血清抗PLA2R抗体阳性患者25例,阳性率45.45%。且治疗前血清抗PLA2R抗体滴度与尿蛋白定量呈正相关,与血清白蛋白、总蛋白呈负相关;治疗6个月后血清抗PLA2R抗体滴度与尿蛋白定量呈正相关,与血清白蛋白、总蛋白呈负相关。结论  血清抗PLA2R抗体可作为IMN血清学诊断的指标之一,血清抗PLA2R抗体滴度下降与尿蛋白的减少密切相关,与疾病预后、病情转归也可能相关。



关 键 词:

特发性膜性肾病  酶联免疫反应  抗M型磷脂酶A2受体抗体

收稿时间:2015/11/26 0:00:00

Correlation between serum anti-PLA2R antibody and adult idiopathic membranous nephropathy
Li-li Zhang,Xiang Wang,Xiao-li Fan,Xiao-li Wang,Jun Zhao.Correlation between serum anti-PLA2R antibody and adult idiopathic membranous nephropathy[J].China Journal of Modern Medicine,2016,26(9):44-48.
Authors:Li-li Zhang  Xiang Wang  Xiao-li Fan  Xiao-li Wang  Jun Zhao
Institution:1. Weifang Medical University, Weifang, Shandong 261042, China; 2. Weifang People''s Hospital, Weifang, Shandong 261000, China
Abstract:

Objective To investigate the relationship between the positive titer of serum anti- phospho-lipase A2 receptor (PLA2R) antibody and other laboratory indexes in adult patients with idiopathic membranous nephropathy (IMN), and to explore the roles of anti-PLA2R antibody in the diagnosis of IMN and the evaluation of the disease severity. Methods Fifty-five IMN patients were selected, and 15 cases of healthy persons were selected as the control group. Serum anti-PLA2R antibody was detected by ELISA. And 24-h urinary protein, serum total protein, serum total cholesterol and serum creatinine were detected in the IMN patients. Results After 3 months and 6 months, the serum anti-PLA2R antibody was significantly lower than that before treatment (P < 0.05). Before treatment 47 of 55 IMN patients were anti-PLA2R antibody positive, the positive rate was 85.45%; 3 months after the treatment there were 36 patients with positive anti-PLA2R antibody, the positive rate was 65.45%; 6 months after treatment, anti-PLA2R antibody positive rate was 45.45% (25/55). The serum anti-PLA2R antibody titer was positively correlated with urinary protein, but was negatively correlated with serum albumin and total protein before treatment and 6 months after treatment. Conclusions Serum anti-PLA2R antibody can be used as one of the serum indexes of IMN, and serum anti-PLA2R antibody titer is closely related to urine protein, which may be closely related to the prognosis and outcome of the disease.

Keywords:

diopathic membranous nephropathy  enzyme linked immune response  anti-PLA2R antibody

点击此处可从《中国现代医学杂志》浏览原始摘要信息
点击此处可从《中国现代医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号